Ascendis Pharma A/S logo

Ascendis Pharma A/S - ADR

2
NAS:ASND (Denmark)   ADR
$ 140.90 -1.28 (-0.9%) 11:08 PM EST
At Loss
Volume:
194.21K
Avg Vol (2M):
314.27K
Also Trade In:
Volume:
194.21K
At Loss
Avg Vol (2M):
314.27K

Business Description

Ascendis Pharma A/S logo
Ascendis Pharma A/S
NAICS : 325411 SIC : 2833
ISIN : US04351P1012

Share Class Description:

ASND: ADR
Description
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Name Current Vs Industry Vs History
Cash-To-Debt 0.62
Equity-to-Asset -0.18
Debt-to-Equity -4.42
Debt-to-EBITDA -1.62
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.95
Distress
Grey
Safe
Beneish M-Score 0.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.14
9-Day RSI 33.91
14-Day RSI 39.74
6-1 Month Momentum % 61.46
12-1 Month Momentum % 80.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.56
Quick Ratio 2.5
Cash Ratio 2.02
Days Inventory 1384.62
Days Sales Outstanding 30.21
Days Payable 930.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.7
Shareholder Yield % -1.1

Financials (Next Earnings Date:2024-04-26 Est.)

ASND's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ASND

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ascendis Pharma A/S Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 288.74
EPS (TTM) ($) -9.213
Beta 0.52
Volatility % 54.49
14-Day RSI 39.74
14-Day ATR ($) 5.063058
20-Day SMA ($) 147.6275
12-1 Month Momentum % 80.93
52-Week Range ($) 66.03 - 161
Shares Outstanding (Mil) 56.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ascendis Pharma A/S Filings

Filing Date Document Date Form
No Filing Data

Ascendis Pharma A/S Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Ascendis Pharma A/S Frequently Asked Questions

What is Ascendis Pharma A/S(ASND)'s stock price today?
The current price of ASND is $140.90. The 52 week high of ASND is $161.00 and 52 week low is $66.03.
When is next earnings date of Ascendis Pharma A/S(ASND)?
The next earnings date of Ascendis Pharma A/S(ASND) is 2024-04-26 Est..
Does Ascendis Pharma A/S(ASND) pay dividends? If so, how much?
Ascendis Pharma A/S(ASND) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1